Daiichi Sankyo – supply chain
Market Position and Market Share Daiichi Sankyo Company, Limited ranks as the 2nd largest pharmaceutical company in Japan by market capitalization (following Takeda Pharmaceutical) and has emerged as the global leader in the next-generation Antibody-Drug Conjugate (ADC) oncology landscape. Supply Chain Upstream, Downstream, and Key Suppliers The ADC supply chain is among the most intricate […]
Daiichi Sankyo – business model
Company History Foundation and Merger Phase (1899–2005) Sankyo was originally founded in 1899, establishing its legacy through digestive enzymes and later statins, while Daiichi Pharmaceutical was founded in 1915, specializing in anti-infectives and synthetic medicines. Both entities grew into cornerstone Japanese pharmaceutical houses throughout the 20th century. In September 2005, facing intensifying global consolidation and […]